Indocyanine Green Compared to Technetium-99m in Sentinel Node Detection in Breast Cancer: A Single-center Retrospective Study
Published: 2024-06-28
Page: 183-189
Issue: 2024 - Volume 7 [Issue 2]
A. Akhdamch *
Gynaecological and Mammary Unit, Sidi Mohamed Ben Abdellah National Institute of Oncology, Rabat, Morocco and Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
M. Anajjar
Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
M. Ben Moussa
Gynaecological and Mammary Unit, Sidi Mohamed Ben Abdellah National Institute of Oncology, Rabat, Morocco.
Y. Alami
Gynaecological and Mammary Unit, Sidi Mohamed Ben Abdellah National Institute of Oncology, Rabat, Morocco and Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
F. Tijami
Gynaecological and Mammary Unit, Sidi Mohamed Ben Abdellah National Institute of Oncology, Rabat, Morocco and Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
H. Hachi
Gynaecological and Mammary Unit, Sidi Mohamed Ben Abdellah National Institute of Oncology, Rabat, Morocco and Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Sentinel lymph node biopsy (SLNB) is a standard procedure in the surgical management of early-stage breast cancer. While the Tc99m radioisotope technique is the gold standard for SLNB, indocyanine green (ICG) fluorescence imaging has emerged as a potential alternative. Our study aimed to evaluate the concordance between ICG and Tc99m in detecting axillary sentinel lymph nodes (SLNs) in breast cancer patients.
Materials and Methods: We conducted a retrospective single-center study between January 2021 and October 2021. Patients with localized breast cancer and indication for axillary SLNB were included. Preoperative Tc99m lymphoscintigraphy and intraoperative ICG fluorescence imaging were performed. The primary outcome was the concordance rate between the two methods in detecting SLNs.
Results: Eleven patients with a total of 34 SLNs were included. The detection rate was 94.1%, with 32 SLNs detected by ICG and 23 by Tc99m. Concordance between the two methods was 67.6%. All discordant SLNs (26.5%) were ICG positive/Tc99m negative, including one micrometastatic SLN detected only by ICG. No complications related to ICG use were observed.
Conclusion: Our study suggests that ICG could be a promising alternative to Tc99m for SLNB in breast cancer, potentially offering higher sensitivity. However, larger prospective studies are needed to confirm these findings and establish standardized protocols for ICG use.
Keywords: Breast cancer, sentinel lymph node biopsy, indocyanine green (ICG), technetium-99m (Tc99m), fluorescence imaging, radioisotope, axillary lymph nodes, concordance, sensitivity
How to Cite
References
Gary H Lyman et al. American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer; 2005.
Saint-paul-de-vence. Recommandation pour la pratique clinique cancer du sein. 2005;342-79.
Gill G, et al. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial. Ann Surg Oncol. 2009;16:266–75.
Barranger E, Classe JM, Clough KB, Giard S, Houvenaeghel G, Nos C. Veille bibliographique et recommandation. Chirurgie du sein et axillaire. RPC NiceSaint-Paul de Vence 2011. Oncologie 2011;13:727–54
Krag DN, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335-9 [discussion 340]
Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis. Cancer 2006;106(1) :4-16.
Zaidi, Nisar Haider, Adnan Merdad, Fatma Khinaifis Althoubaity, Nouf Yahya Akeel, and Abdullah Omar Sultan. Sentinel lymph node biopsy in breast carcinoma: A tertiary center experience. Journal of Advances in Medicine and Medical Research. 2017;19(10):1-8.
Available:https://doi.org/10.9734/BJMMR/2017/30919.
Nur, Fateha, Shah Md. Badruddoza, Asafudullah SM. Evaluation of histopathological diagnosis and determination of grades and stages in breast cancer. Asian Journal of Medicine and Health. 2022;20 (11):204-11.
Available:https://doi.org/10.9734/ajmah/2022/v20i11760.
O’Hea BJ, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PI, Cody III HS. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. Journal of the American College of Surgeons. 1998 Apr 1;186(4):423-7.
Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. Journal of the American College of Surgeons. 1999 Aug 1;189(2):183-94.
Sugie T, et al. A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer Cancers (Basel). 2010;2(2):713—20.
Yamamoto S, et al. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography. Breast 2013;22(5):933—7.
Ballardini B, Santoro L, Sangalli C, et al. The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study. Eur J Surg Oncol. 2013;39(12):1332—6.
White KP, Sinagra D, Dip F, Rosenthal RJ, Mueller EA, Lo Menzo E, Rancati A. Indocyanine green fluorescence versus blue dye, technetium-99M, and the dual-marker combination of technetium-99M þ blue dye for sentinel lymph node detection in early breast cancer—meta-analysis including consistency analysis. Surgery. 2024 Jan 1;175:963-73.
Guenane Y*, Gorj M, Nguyen V, et al. Évaluation du vert d’Indocyanine versus Technétium dans la détection du ganglion sentinelle dans le cancer du sein. Annales de Chirurgie Plastique Esthétique. December 2016;61(6):806-810.
Goonawardena J, Yong C, Law M. Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: Systematic review and meta-analysis. Am J Surg. 2020;220: 665e676.
Samorani D, Fogacci T, Panzini I, et al. The use of indocyanine green to detect sentinel nodes in breast cancer: A prospective study. Eur J Surg Oncol. 2015;41(1):64—70.
Francesco Giammarile MD, PhD, Sergi Vidal-Sicart MD, et al. Sentinel lymph node methods in breast cancer. Seminars in Nuclear Medicine. September 2022;52(5):551-560.
Alius C, Oprescu S, Balalau C, Nica AE. Indocyanine green enhanced surgery; principle, clinical applications and future research directions. J Clin Invest Surg. 2018;3(1):1-8.
DOI: 10.25083/2559.5555/31.18